Luxexcel, a developer of 3D printing technology and services for ophthalmic lenses, announced a few days ago that it has raised another €13 million from Innovation Industries, a Dutch-based investment fund, together with other financial investors in the Netherlands, Belgium and Germany and with KLA Tencor Corporation, a U.S. technology firm in the semiconductor and nanoelectronics industries. The company had already raised €14 million last year in two rounds, as previously reported (see Eyewear Intelligence Vol. 18 n°12+13).
Luxexcel provides ophthalmic laboratories with its Vision Platform, an all-in-one solution including a 3D printer, raw material (resins) and dedicated software, in exchange for a base fee and additional fees for each produced lens. It opened a U.S. subsidiary in January of this year in Alpharetta, near Atlanta. There are currently two Vision Platform setups installed in the country, and another one in Luxexcel's Belgian office.
The newly raised funds will help the Dutch company to finance ongoing product developments and ramp up commercialization. The company also announced today that it is opening a customer-demonstration laboratory in its American office in order to preview its Vision Platform technology for U.S.-based laboratories.
A few days earlier, Luxexcel appointed Fabio Esposito as its new chief executive. Esposito is replacing Hans Streng, who is leaving the company after a year and a half in that position but will remain an advisor to the board. Esposito will be in charge of strategic, financial and operational growth, bringing more than 20 years of experience with companies such as Solidscape, a provider of high-precision 3D printers for manufacturing, and ISRA Parsytec, described as a global supplier of machine vision systems such as optical robots and machine learning.